Oculus Ammends Terms

Oculus Innovative Sciences Inc., a Petaluma, Calif.-based developer of products intended to help prevent and treat infections in chronic and acute wounds, has amended its IPO terms. It now plans to offer 3.5 million common shares between $8 and $10 per share, as opposed to earlier plans to offer around 3.08 million shares at between $12 and $14 per share. It still plans to trade on the Nasdaq under ticker symbol OCLS, with Roth Capital Partners serving as lead underwriter. Oculus has raised over $56 million in private equity funding, from firms like Western Technology Investment and Brookstreet Securities. www.oculusis.com